Trials / Not Yet Recruiting
Not Yet RecruitingNCT05602103
Cancer Therapy-related Cardiac Dysfunction Occuring in Children Treated by Anticancer Drugs for Malignancies
Identification of Anticancer Drugs Associated With Cancer Therapy-related Cardiac Dysfunction Reporting in Pediatrics - Analysis of the WHO Pharmacovigilance Database
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 10,000 (estimated)
- Sponsor
- University Hospital, Caen · Academic / Other
- Sex
- All
- Age
- 0 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
Little is known about cancer therapy-related cardiac dysfunction occuring in children treated by anticancer drugs for malignancies. Here the investigators use VigiBase (http://www.vigiaccess.org/), the World Health Organization (WHO) database of individual safety case reports, to identify and describe cases of cancer therapy-related cardiac dysfunction associated with anticancer drugs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | use of anticancer drugs in monotherapy or in combination therapy | Cases of cancer therapy-related cardiac dysfunction associated with anticancer drugs will be identify and describe |
Timeline
- Start date
- 2024-11-05
- Primary completion
- 2025-01-01
- Completion
- 2025-01-06
- First posted
- 2022-11-01
- Last updated
- 2024-05-29
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05602103. Inclusion in this directory is not an endorsement.